⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10877176 | 0.78 | — | — | |
| SCHEMBL14273838 | 0.73 | — | — | |
| SCHEMBL1548502 | 0.71 | — | — | |
| SCHEMBL8371147 | 0.69 | — | — | |
| SCHEMBL1887408 | 0.69 | — | — | |
| SCHEMBL28667023 | 0.69 | — | — | |
| SCHEMBL11475094 | 0.69 | — | — | |
| Arsenic SCHEMBL8413721 | 0.67 | — | — | |
| SCHEMBL28564576 | 0.65 | — | — | |
| SCHEMBL9355511 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080051451-A1 | Autoimmune conditions and NADPH oxidase defects | BIOVITRUM AB (SE) | 2008-02-28 | — | — | US | disclosed |
| US-20080051451-A1 | Autoimmune conditions and NADPH oxidase defects | BIOVITRUM AB (SE) | 2008-02-28 | — | — | US | disclosed |
| WO-2007104790-A1 | AUTOIMMUNE CONDITIONS AND NADPH OXIDASE DEFECTS | BIOVITRUM AB (PUBL) (SE) | 2007-09-20 | — | — | WO | disclosed |
| US-5077046-A | Plant extracts; mannaliam dolichols intermediates | KURARAY CO., LTD. (JP) | 1991-12-31 | — | — | US | disclosed |